Ferrous glycine is used widely as third-generation organic iron at present. Nutritionists unanimously recognize it is absorpt quickly in the animal intestinal tract, higher utilization rate, with good functions of blood-producing and oxygen-carrying. After the organism absorb ferrous glycine, can convert into more heme rapidly. Ferrous glycine has a outstanding effect for improving animal fur and growth performance Light yellow crystal or crystalline powder
NEW XIENCE SIERRA STENT DESIGN The new XIENCE Sierra Stent Design, with Slim Flex Technology, has a lower crossing profile1 and greater post-dilatation expansion NEW STENT DELIVERY SYSTEM FOR COMPLEX CASES Design innovations built to provide the flexibility, crossability, and pushability needed for even the most complex cases. The XIENCE V®, XIENCE nano®, XIENCE PRIME®, XIENCE PRIME® LL, XIENCE Xpedition®, XIENCE Xpedition® SV and XIENCE Xpedition® LL , XIENCE Alpine®, and XIENCE SierraTM (XIENCE Family) of Everolimus Eluting Coronary Stents on the MULTI-LINK VISION® or MULTI-LINK MINI VISION® Delivery System INDICATIONS The XIENCE Sierra stent system is indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions (length â?¤ 32 mm) with reference vessel diameters of â?¥ 2.25 mm to â?¤ 4.25 mm. In addition, the XIENCE Sierra stent system is indicated for treating de novo chronic total coronary occlusions. CONTRAINDICATIONS The XIENCE Sierra stent system is contraindicated for use in: Patients who cannot tolerate, including allergy or hypersensitivity to, procedural anticoagulation or the post-procedural antiplatelet regimen. Patients with hypersensitivity or contraindication to everolimus or structurally related compounds, or known hypersensitivity to stent components (cobalt, chromium, nickel, tungsten, acrylic, fluoropolymers), or with contrast sensitivity. WARNINGS It is not recommended to treat patients having a lesion that prevent complete inflation of an angioplasty balloon. Judicious patient selection is necessary because the use of this device carries the associated risk of stent thrombosis, vascular complications, and/or bleeding events. This product should not be used in patients who are not likely to comply with the recommended antiplatelet therapy.
The second-generation Xience V everolimus-eluting stent incorporates advanced design features such as a cobalt-chromium stent platform coated with an antirestenotic drug, everolimus, incorporated into a biocompatible polymer with a long history of medical use. The efficacy of the stent has been demonstrated with low rates of angiographic restenosis, whilst randomized trials comparing the Xience V everolimus-eluting stent to the first-generation Taxus paclitaxel-eluting stent have found a reduction in repeat revascularization rates. Further randomized trials, including 'all-comer' patients and registries of unselected patients are currently further evaluating the efficacy and safety of the Xience V stent in high-risk, complex cases.We also offer one of the most primary quality stents in the market, The Xience V Stent Coronary artery stents are devices (small metallic mesh tubes) that are placed over a balloon catheter and delivered to the narrowed portion of the coronary artery. The balloon is used to expand the stent. The stent presses against the narrowed vessel wall, holding the vessel open. This results in a wider artery channel to improve blood flow to the heart muscle. This may be followed by repeat balloon inflations within the stent to achieve the result desired by your doctor. Once the balloon has been deflated and withdrawn, the stent stays in place permanently, holding the coronary artery open. The inner lining of the artery grows over the surface of the stent, making the stent a permanent part of your artery
The EverFlex stent is designed for use in the treatment of peripheral arterial disease (PAD), specifically in the iliac arteries. Key features of the EverFlex Protege stent may include: Self-Expanding Design: The stent is self-expanding, meaning it can open and conform to the shape of the artery without the need for balloon inflation. Nitinol Construction: The stent is typically made of nitinol, a nickel-titanium alloy known for its flexibility and ability to maintain shape memory. Longitudinal Flexibility: The stent is designed to provide longitudinal flexibility, allowing it to adapt to the natural movement of the vessel. Iliac Artery Treatment: The EverFlex Protege stent is specifically indicated for use in the iliac arteries, which are located in the pelvis.
Terumo is a well-known medical device company, and Ultimaster is a brand associated with their drug-eluting stent (DES) products. Drug-eluting stents are devices used in interventional cardiology to treat coronary artery disease.
Biosensors is a medical device company known for its innovations in interventional cardiology, particularly in the field of coronary stents. The BioMatrix platform includes a range of drug-eluting stents (DES) designed to be used in the treatment of coronary artery disease. Key features of the BioMatrix stent platform, which may extend to the NeoFlex model if it's a part of the series, may include: Drug-Eluting Stent: The stents in the BioMatrix platform are drug-eluting, meaning they are coated with a medication (such as an anti-restenotic drug) designed to inhibit the regrowth of tissue inside the treated blood vessel. Biodegradable Polymer: Some versions of the BioMatrix stent use a biodegradable polymer to deliver the drug to the target site. The polymer gradually dissolves over time, leaving only the metallic stent behind. Flexible Design: The stents are designed to be flexible, allowing for easier navigation and deployment in the coronary arteries. Thin-Strut Technology: Thin struts can contribute to improved deliverability and conformability of the stent to the vessel wall. Various Sizes: The BioMatrix stent platform typically offers stents in various sizes to accommodate different patient anatomies and lesion characteristics.
the Boston Scientific Promus Elite is a coronary drug-eluting stent system. It is designed for use in patients undergoing percutaneous coronary intervention (PCI) procedures to treat coronary artery disease. Here are some key features and points related to the Boston Scientific Promus Elite coronary stent: Drug-Eluting Stent: The Promus Elite is a drug-eluting stent (DES), meaning it is coated with medication to help prevent the re-narrowing (restenosis) of the treated coronary artery. Drug Coating: The stent typically features a polymer coating containing an anti-proliferative drug. This drug is slowly released over time to inhibit the growth of tissue inside the stent, reducing the risk of restenosis. Cobalt Chromium Alloy: The stent is often made of a cobalt chromium alloy, known for its strength and flexibility. This material allows for a thin stent strut design, which can be beneficial in terms of deliverability and conformability. Delivery System: The stent is delivered to the target area using a catheter-based delivery system. The catheter is guided through the blood vessels to the site of the coronary artery lesion. Radiopaque Markers: Radiopaque markers on the stent aid in proper placement and visualization under X-ray guidance during the procedure.
Endopyelotomy Stent
Material Number: M0031681890 Description: Straight, 2-tip marker Total / Distal Length: 150cm/6.0cm The Excelsior SL-10 Microcatheter with Thin Wall Technology and Lubricious Hydrolene�® Outer Surface is designed to provide outstanding performance 1.7F (0.56mm) Low Profile Distal Shaft, Excelsior SL-10 Microcatheter is designed with a low profile tip to enhance access to distal vasculature and ease of passage of the catheter trip through stent interstices. Atraumatic Distal Tip, Specifically engineered for atraumatic access, the rounded, low-durometer, unbraided tip offers exceptional softness and flexibility. Variety of Tip Shapes, Offered in six clinically relevant shapes to improve access and navigability.
